# FEC With G-CSF Support Followed by Ixabepilone With G-CSF Support as Neoadjuvant Chemotherapy in BC

> **NCT00751868** · PHASE2 · COMPLETED · sponsor: **Consorzio Oncotech** · enrollment: 47 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Ixabepilone

## Key facts

- **NCT ID:** NCT00751868
- **Lead sponsor:** Consorzio Oncotech
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2014-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00751868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00751868, "FEC With G-CSF Support Followed by Ixabepilone With G-CSF Support as Neoadjuvant Chemotherapy in BC". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT00751868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*